Tag: COVID-19
NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients
February 6, 2021
A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…
READ MORE
NANETS Webinar on COVID-19 for the Neuroendocrine Tumor Community
April 20, 2020
A panel of 10 neuroendocrine tumor (NET) medical experts will gather for an online conversation about COVID-19 and its impact on NET patients. Patients, families, and caregivers are invited to submit questions and panelists will answer as many as possible…
READ MORE
